You just read:

Array BioPharma Announces Additional Median Overall Survival Results of Encorafenib and Binimetinib in Patients with BRAF-mutant Advanced Melanoma

News provided by

Array BioPharma Inc.

Jun 04, 2018, 08:00 ET